13. Selection of Optimal Adjuvants and Product Factors that Affect Vaccine Immunogenicity

  1. Manmohan Singh and
  2. Indresh K. Srivastava
  1. Wei Wang1 and
  2. Manmohan Singh2

Published Online: 6 JUN 2011

DOI: 10.1002/9781118023648.ch13

Development of Vaccines: From Discovery to Clinical Testing

Development of Vaccines: From Discovery to Clinical Testing

How to Cite

Wang, W. and Singh, M. (2011) Selection of Optimal Adjuvants and Product Factors that Affect Vaccine Immunogenicity, in Development of Vaccines: From Discovery to Clinical Testing (eds M. Singh and I. K. Srivastava), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118023648.ch13

Editor Information

  1. Novartis Vaccines, Cambridge, Massachusetts, USA

Author Information

  1. 1

    Pfizer, Inc., Chesterfield, Missouri, USA

  2. 2

    Novartis Vaccines, Cambridge, Massachusetts, USA

Publication History

  1. Published Online: 6 JUN 2011
  2. Published Print: 18 JUL 2011

ISBN Information

Print ISBN: 9780470256374

Online ISBN: 9781118023648

SEARCH

Keywords:

  • optimal adjuvant selection - and product factors, affecting vaccine immunogenicity;
  • virus replicon particles (VRP), effective - systemic, cellular and mucosal adjuvants;
  • drug product-related factors, vaccine immunogenicity effects - dose, antigen type and combinations

Summary

This chapter contains sections titled:

  • Introduction

  • Vaccine-Induced Immunological Responses

  • Aluminum Salts

  • Nonaluminum Adjuvants

  • Other Product-Related Factors

  • Summary

  • References